Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Devillier

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Research Quarterly for Exercise and Sport|September 1, 1991
The validity of academic learning time-physical education (ALT-PE) as a process measure of achievementS Silverman, R Devillier, T Ramírez
Bone Marrow Transplantation|February 23, 2010
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningT Prébet, R Devillier, S Fürst, et al.
The American Review of Respiratory Disease|November 1, 1989
The utility of bronchoalveolar lavage and transbronchial lung biopsy combined with energy-dispersive X-ray analysis in the diagnosis of silicosisK M Nugent, R F Dodson, S Idell, et al.
Journal of Neuro-Oncology|November 27, 2015
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcomeE Tabouret, C Boucard, R Devillier, et al.
Bone Marrow Transplantation|December 11, 2012
TLI in refractory chronic GVHDR Devillier, L Castagna, L Gonzague, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|July 19, 2016
The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideA Rimondo, R Crocchiolo, J El-Cheikh, et al.
Bone Marrow Transplantation|December 13, 2016
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AMLF Legrand, A-C Le Floch, A Granata, et al.
Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.
Bone Marrow Transplantation|October 18, 2016
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantationL Castagna, B Sarina, R Crocchiolo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Research Quarterly for Exercise and Sport|September 1, 1991
The validity of academic learning time-physical education (ALT-PE) as a process measure of achievementS Silverman, R Devillier, T Ramírez
Bone Marrow Transplantation|February 23, 2010
Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioningT Prébet, R Devillier, S Fürst, et al.
The American Review of Respiratory Disease|November 1, 1989
The utility of bronchoalveolar lavage and transbronchial lung biopsy combined with energy-dispersive X-ray analysis in the diagnosis of silicosisK M Nugent, R F Dodson, S Idell, et al.
Journal of Neuro-Oncology|November 27, 2015
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcomeE Tabouret, C Boucard, R Devillier, et al.
Bone Marrow Transplantation|December 11, 2012
TLI in refractory chronic GVHDR Devillier, L Castagna, L Gonzague, et al.
Bone Marrow Transplantation|February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCTR Devillier, R Crocchiolo, L Castagna, et al.
Bone Marrow Transplantation|July 19, 2016
The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamideA Rimondo, R Crocchiolo, J El-Cheikh, et al.
Bone Marrow Transplantation|December 13, 2016
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AMLF Legrand, A-C Le Floch, A Granata, et al.
Bone Marrow Transplantation|November 10, 2015
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromesR Devillier, S Bramanti, S Fürst, et al.
Bone Marrow Transplantation|October 18, 2016
Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantationL Castagna, B Sarina, R Crocchiolo, et al.
Pageof 2